Background

Recent work shows that age‑related rise of epigenetic regulators BAZ‑2 and SET‑6/EHMT1 suppresses nuclear‑encoded mitochondrial genes, lowering respiration and accelerating decline [1]. Mitochondrial TCA metabolites, especially α‑ketoglutarate, feed back to modify histones, linking organelle output to chromatin state [2]. This creates a bidirectional loop where epigenetic silencing starves mitochondria, which then fails to supply metabolites needed for open chromatin.

Hypothesis

We propose that the epigenetic‑mitochondrial feedback loop acts as a self‑amplifying circuit that, once tipped past a threshold, drives the coordinated emergence of multiple aging hallmarks (epigenetic drift, mitochondrial dysfunction, loss of proteostasis, cellular senescence, and chronic inflammation). Breaking the loop at both nodes simultaneously—by inhibiting the upstream epigenetic silencers and replenishing TCA metabolites—should produce a synergistic reversal that exceeds the sum of each single intervention.

Predictions

If the hypothesis is correct, then:

• Simultaneous RNAi knock‑down of BAZ‑2/SET‑6 and α‑ketoglutarate supplementation will restore mitochondrial respiration to youthful levels in aged C. elegans, mice, and human fibroblasts.
• This combined treatment will reduce senescence‑associated secretory phenotype (SASP) markers and improve proteostasis reporters more than either manipulation alone.
• Epigenetic age clocks (e.g., Horvath’s pan‑tissue clock) will show a significant setback only when both nodes are targeted.
• Disrupting only one node will yield partial improvement but will not prevent rebound of the loop within a defined time window (e.g., 2 weeks in worms, 1 month in mice).
• Artificially decoupling the loop—forcing mitochondrial export of α‑ketoglutarate while maintaining BAZ‑2 expression—will prevent the setback, confirming directionality.

Experimental Design

Model systems: Use C. elegans strains with inducible BAZ‑2/SET‑6 RNAi, aged mice with CRISPRi targeting Baz2 and Ehmt1, and primary human fibroblasts from donors >65 y. Interventions:

1. Epigenetic node: inducible RNAi/CRISPRi of BAZ‑2 and SET‑6/EHMT1.
2. Mitochondrial node: α‑ketoglutarate supplementation (2 mM in worm media, 1 mM in mouse drinking water, 0.5 mM in culture).
3. Combined: both interventions applied concurrently. Readouts:

• Oxygen consumption rate (Seahorse) for mitochondrial function.
• Global histone acetylation/methylation (Western blot, mass spec).
• Transcriptomic profiling of mitochondrial and ribosomal gene sets.
• Proteostasis reporters (e.g., HSP‑16::GFP, luciferase‑based degradation sensors).
• Senescence markers (p16^INK4a, SASP cytokines IL‑6, IL‑8).
• Epigenetic clock readout (bisulfite sequencing of CpG sites linked to RAB32 methylation).
• Lifespan/healthspan metrics (motility, frailty index, grip strength). Analysis: Compare each single treatment to combined using two‑way ANOVA; test for synergy via Bliss independence model.

Potential Outcomes

• Synergistic rescue: Combined treatment yields > additive improvement in respiration, histone marks, and functional readouts, confirming loop amplification.
• Partial rescue: Only single‑node effects observed, suggesting the loop is not dominant or additional regulators exist.
• No effect: Interventions fail to alter markers, indicating the observed correlations are epiphenomenal or that compensatory pathways maintain the loop. Each outcome is falsifiable: a lack of significant improvement in the combined arm relative to the best single arm would refute the hypothesis of a synergistic bidirectional controller.